Picture of Achilles Therapeutics logo

ACHL Achilles Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Achilles Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUSPROSPECTUS20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments10.797.6178266173
Net Total Receivables0.0010.3271.130.650.771
Prepaid Expenses
Total Other Current Assets
Total Current Assets13.4103188285197
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.5832.1128.128.820.5
Other Long Term Assets
Total Assets14105219317220
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.293.8616.619.118
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.293.8629.527.623.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity12.7101189290197
Total Liabilities & Shareholders' Equity14105219317220
Total Common Shares Outstanding